GAMMA Investing’s PetMed Express PETS Stock Holding History

GAMMA Investing’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-47	Closed	-$225	–	3497
2024 Q1	$225	Hold	47	–	–	﹤0.01%	3216
2023 Q4	$292	Buy	+47	New	+$386	﹤0.01%	3065

Other funds holding PETS

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $2.35B AUM 214.39% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GAMMA Investing's PETS Position: Q2 2024 in Review

GAMMA Investing sold out of PetMed Express (PETS) in Q2 2024, closing a stake of 47 shares — an estimated $225 sold.

GAMMA Investing first reported a position in PETS in Q4 2023 and held it in 2 quarters. The position peaked at $292 in Q4 2023. 117 funds tracked by Wall St. Rank hold PETS as of Q2 2024.

GAMMA Investing reported no remaining PetMed Express position as of Q2 2024 after selling out during the quarter.
GAMMA Investing sold 47 PetMed Express shares in Q2 2024, an estimated $225.
GAMMA Investing first reported a position in PetMed Express in Q4 2023 and held it in 2 quarters.
GAMMA Investing's PetMed Express position peaked at $292 in Q4 2023.
117 funds tracked by Wall St. Rank held PetMed Express as of Q2 2024.

Based on GAMMA Investing's 13F filing for Q2 2024, filed 2 Jul 2024.